2型糖尿病处方合理性评价标准的建立

Establishment of rationality evaluation criteria for prescriptions of type 2 diabetes mellitus

目的建立2型糖尿病处方合理性评价标准,为不同医疗机构的药师提供统一的点评依据。方法随机抽取北京市22家医院2017年6月5日—9日的门急诊全部处方,利用处方点评软件对其中的32682张2型糖尿病处方进行分析,针对典型问题设计标准架构,参考说明书和指南建立处方合理性评价标准。结果2型糖尿病处方的不合理问题主要涉及药物的适应证、人群、用法用量、禁忌证和相互作用。本研究建立了非胰岛素降糖药物、胰岛素、糖尿病并发症用药三类药物的处方评价标准。结论2型糖尿病处方合理性评价标准可以为药师提供一个基于说明书和指南的简洁、凝练的处方评价体系,保持点评尺度的统一性,保证点评标准的时效性,提高处方评价工作的效率。

Objective:To establish criteria for evaluating rationality of prescriptions for type 2 diabetes mellitus,and provide a unified basis for pharmacists in different medical institutions.Methods:All outpatient and emergency prescriptions of 22 hospitals in Beijing from June 5 to 9,2017 were randomly selected.32 682 prescriptions of type 2 diabetes mellitus were analyzed by prescription evaluation software,standard framework for typical problems was designed,standard framework for typical problems was designed,and the evaluation criteria of rationality for prescription was formulated referring to package inserts and guidelines.Results:The irrational items in the prescriptions of type 2 diabetes mellitus mainly involved indication,population,usage,contraindication and drug interactions.This study established the prescription evaluation criteria for non-insulin hypoglycemic drugs,insulin and drugs for diabetic complications.Conclusion:The criteria for evaluating the rationality of prescriptions for type 2 diabetes mellitus provides a concise prescription evaluation system for pharmacists based on package inserts and guidelines,which can improve the efficiency of prescription evaluation,maintain the uniformity of evaluation criteria,and ensure the timeliness of evaluation criteria.